4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-21-047868
Director sold 5,721 shares at an average $16.81 ($96,148)
- Director acquired 5,721 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2021-07-20 | Option exercise | +2,106 | $13.80 | $29,063 | 282,679 | D: show line 1 in the form |
| CHESS ROBERT Director | 2021-07-20 | Sale | −2,106 | $16.80 | $35,381 | 280,573 | D: show line 2 in the form |
| CHESS ROBERT Director | 2021-07-21 | Option exercise | +3,524 | $13.80 | $48,631 | 284,097 | D: show line 3 in the form |
| CHESS ROBERT Director | 2021-07-21 | Sale | −3,524 | $16.81 | $59,238 | 280,573 | D: show line 4 in the form |
| CHESS ROBERT Director | 2021-07-22 | Option exercise | +91 | $13.80 | $1,256 | 280,664 | D: show line 5 in the form |
| CHESS ROBERT Director | 2021-07-22 | Sale | −91 | $16.80 | $1,529 | 280,573 | D: show line 6 in the form |
| Open-market sales · 5,721 sh · avg $16.81 · $96,148 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2021-07-20 | Option exercise · Stock Option | −2,106 | 21,894 | D: show line 7 in the form | |||||
| CHESS ROBERT Director | 2021-07-21 | Option exercise · Stock Option | −3,524 | 18,370 | D: show line 8 in the form | |||||
| CHESS ROBERT Director | 2021-07-22 | Option exercise · Stock Option | −91 | 18,279 | D: show line 9 in the form |
Loading xslF345X03/doc4.xml…